SIMPLEX TRADING, LLC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 166 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$25
+13.6%
1,384
-31.7%
0.00%
Q2 2023$22
-95.2%
2,027
-94.1%
0.00%
Q1 2023$462
-99.2%
34,462
+753.9%
0.00%
Q3 2022$56,000
+273.3%
4,036
+270.3%
0.00%
Q2 2022$15,000
-94.2%
1,090
-93.2%
0.00%
Q1 2022$259,000
+600.0%
15,950
+963.3%
0.00%
Q4 2020$37,000
-40.3%
1,5000.0%0.00%
Q3 2020$62,000
-12.7%
1,5000.0%0.00%
Q2 2020$71,000
-95.8%
1,500
-89.0%
0.00%
-100.0%
Q4 2019$1,689,000
+859.7%
13,634
+412.7%
0.00%
+300.0%
Q3 2019$176,000
-91.6%
2,659
-85.8%
0.00%
-83.3%
Q1 2019$2,095,000
+391.8%
18,729
+342.7%
0.01%
+500.0%
Q4 2018$426,000
-70.7%
4,231
-63.2%
0.00%
-80.0%
Q3 2018$1,453,000
+179.4%
11,502
+85.4%
0.01%
+150.0%
Q2 2018$520,000
+6.8%
6,203
-21.8%
0.00%
-90.5%
Q1 2018$487,000
+116.4%
7,931
+105.7%
0.02%
+110.0%
Q4 2017$225,000
-46.0%
3,856
+11.8%
0.01%
-44.4%
Q2 2017$417,000
-32.3%
3,448
-36.7%
0.02%
-33.3%
Q1 2017$616,000
-51.2%
5,447
-53.1%
0.03%
-64.0%
Q4 2016$1,262,000
-46.3%
11,619
-29.4%
0.08%
-52.2%
Q2 2016$2,349,000
+221.3%
16,469
+236.2%
0.16%
+175.4%
Q4 2015$731,000
+31.7%
4,899
+46.3%
0.06%
+39.0%
Q3 2015$555,000
-40.3%
3,348
-13.0%
0.04%
-47.4%
Q2 2015$929,000
-58.5%
3,849
-51.5%
0.08%
-70.0%
Q1 2015$2,236,0007,9290.26%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 640,688$14,787,0002.73%
DeepCurrents Investment Group LLC 416,800$9,620,0000.33%
DUALITY ADVISERS, LP 105,668$2,439,0000.21%
EULAV Asset Management 335,000$7,732,0000.21%
Virtus ETF Advisers LLC 19,375$447,0000.19%
Hennion & Walsh Asset Management, Inc. 135,214$3,121,0000.19%
PDT Partners, LLC 110,592$2,552,0000.18%
KETTLE HILL CAPITAL MANAGEMENT, LLC 70,256$1,622,0000.16%
ALTRINSIC GLOBAL ADVISORS LLC 168,800$3,896,0000.12%
WOODWARD DIVERSIFIED CAPITAL, LLC 8,939$206,0000.12%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders